Form D · Pharmaceuticals
Isla Pharmaceuticals, Inc.
San Juan, PR · CIK 0001758855
Offering snapshot reported Mar 18, 2020 · SEC filing
- Reported sold
- $563K Offering amount: $1.5M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $12.5K Reported outside-investor minimum
- First sale
- Mar 6, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 18, 2020 | Initial | $562,872 | No comparison | 6 | SEC filing |
| Feb 15, 2019 | Amendment | $1,125,012 | $0vs Nov 15, 2018 | 16 | SEC filing |
| Nov 15, 2018 | Initial | $1,125,012 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-363179
Source: Form D, filed Mar 18, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Charles Foster | Director, Executive |
| William James Garner | Director |
| Joseph Isadore Green | Director |
| Albert Hansen | Director |
| Paul Donald Richard Mac Leman | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
100 Calle Del Muelle, 21007
San Juan, PR, 00901
San Juan, PR, 00901